Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jaad.2017.08.023 | DOI Listing |
Front Med (Lausanne)
September 2024
Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, United States.
Introduction: The healthcare system in the United States relies heavily on physician-and house officer-driven initiation of billing and coding for collection of hospital payments and professional fees. Under the umbrella of practice management is the ever-changing and suboptimally taught concept of procedural billing and coding to house officers and faculty. Clinical providers and practitioners initiate billing and coding for performed services based on the procedural visit encounter, supported by the appropriate documentation.
View Article and Find Full Text PDFAktuelle Urol
February 2023
Klinik für Urologie, Charité - Universitätsmedizin Berlin, Berlin, Deutschland.
Background: OnabotulinumtoxinA (Botox) has been approved in Germany since 2013 for the second-line treatment of idiopathic overactive bladder in the form of a detrusor injection (OnabotA DI) after failure of anticholinergic therapy. Until 2018, however, its application lagged far behind the demand due to billing hurdles. Since the beginning of 2018, there has been an EBM (German Uniform Evaluation Standard) approval number in Germany for the transurethral application of Botox in urology.
View Article and Find Full Text PDFAm Surg
September 2022
Department of Surgery, 24520New Hanover Regional Medical Center, Wilmington, NC, USA.
Background: Despite various resources on the subject, there remain questions regarding billing and coding hernia surgery. Recently, social media has been used to disseminate information in about surgery. The purpose of this project is to evaluate posts relating to coding through one online social media platform.
View Article and Find Full Text PDFJ Hand Surg Am
May 2021
Department of Orthopaedic Surgery, Washington University School of Medicine, St Louis, MO. Electronic address:
Purpose: The purpose of this study was to compare the cost-effectiveness of surgical release to botulinum toxin injections in the treatment of upper-extremity (UE) cerebral palsy (CP).
Methods: A Markov transition-state model was developed to assess the direct and indirect costs as well as accumulated quality-adjusted life-years associated with surgery (surgery group) and continuous botulinum toxin injections (botulinum group) for the treatment of UE CP in children aged 7 to 12 years. Direct medical costs were obtained from institutional billing departments.
J Am Acad Dermatol
April 2018
Department of Dermatology and Cutaneous Biology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!